SOFT TISSUE SARCOMA (EXCLUDING GIST)
Clinical trials for SOFT TISSUE SARCOMA (EXCLUDING GIST) explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA (EXCLUDING GIST) trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA (EXCLUDING GIST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to stall sarcoma growth in patients Who've tried other treatments
Disease control Not yet recruitingThis study tests a combination of three drugs (liposomal irinotecan, temozolomide, and bevacizumab) in 24 people with advanced soft tissue sarcoma that has come back or not responded to prior treatment. The goal is to see if the combo can slow tumor growth and control the disease…
Matched conditions: SOFT TISSUE SARCOMA (EXCLUDING GIST)
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
New radiation schedule aims to improve sarcoma control before surgery
Disease control Not yet recruitingThis study tests a shorter, more intense radiation schedule given before surgery for soft tissue sarcoma in the arms, legs, or trunk. The goal is to see if this approach can better prevent the cancer from coming back in the same area. About 135 adults will receive 15 radiation se…
Matched conditions: SOFT TISSUE SARCOMA (EXCLUDING GIST)
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated May 22, 2026 13:51 UTC